News

Citius Pharmaceuticals Sees Growth with $12.5 Million Raised

Citius Pharmaceuticals Sees Growth with $12.5 Million Raised

Citius Pharmaceuticals Reports Strong Financial Results

Citius Pharmaceuticals, Inc., a biopharmaceutical organization focused on critical care products, recently showcased its latest financial performance, emphasizing growth and strategic initiatives. The company successfully raised $12.5 million in gross financings during the latest quarter. Additionally, its oncology subsidiary secured $9 million in July to support the upcoming launch of LYMPHIR, set for the fourth quarter.

Advancements in Product Launch

Chairman and CEO Leonard Mazur commented on the firm’s progress, stating, "Citius is transitioning from development to a fully integrated commercial entity. Preparations are ongoing for the U.S. launch of LYMPHIR™, targeting a significant market segment with unmet medical needs." This targeted immunotherapy aims to treat cutaneous T-cell lymphoma, a condition that demands innovative treatment solutions.

Financial Highlights for Fiscal Third Quarter 2025

During this fiscal quarter, Citius reported various financial metrics:

  • R&D expenses totaled $1.6 million, a decrease from last year’s $2.8 million.
  • G&A expenses stood at $4.4 million, down from $4.8 million in the previous year.
  • Stock-based compensation was recorded at $2.7 million, compared to $3.1 million previously.
  • The net loss reached $9.2 million, translating to $0.80 per share, an improvement over a loss of $10.6 million or $1.57 per share last year.
  • Cash and cash equivalents as of the quarter-end totaled $6.1 million.

Comprehensive Financial Discussions

To delve deeper into the company's financial performance, it is recommended to review their Quarterly Report on Form 10-Q. This comprehensive document provides additional insights into the company’s financial standings and operational strategies moving forward.

Company Overview: Citius Pharmaceuticals

Citius Pharmaceuticals is devoted to developing and commercializing innovative solutions for critical care. The firm’s portfolio includes LYMPHIR™, which was approved by the FDA for treating T-cell lymphoma, alongside Mino-Lok®, an antibiotic lock solution designed to mitigate catheter-related bloodstream infections.

With a strategic focus on growth, Citius aims to enhance its offerings and positively impact patient care. Currently, it maintains an 84% ownership stake in Citius Oncology, enabling further market penetration and product development.

Frequently Asked Questions

What is the focus of Citius Pharmaceuticals?

Citius Pharmaceuticals specializes in developing critical care biopharmaceutical products with a focus on innovative treatment solutions.

What recent financial achievement did Citius Pharmaceuticals attain?

The company raised a total of $12.5 million in gross financings during the recent quarter to advance its product offerings.

What is LYMPHIR and its significance?

LYMPHIR is a targeted immunotherapy evaluated for treating cutaneous T-cell lymphoma, addressing a critical need in oncology.

How did Citius Pharmaceuticals perform financially in the third quarter?

In the fiscal third quarter of 2025, Citius reported a net loss of $9.2 million, showing improvements in R&D and operational expenses compared to the previous year.

Where can interested parties learn more about Citius Pharmaceuticals?

For detailed information, stakeholders can refer to the company’s official website and its financial filings with the SEC.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 7

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 10

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 5

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 5

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 6

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Avive Partners with Cambridge Fire for Lifesaving Training

Updated Category News Views 7

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 8

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Feeding Families Foundation Gains $121,500 for NYC Push

Updated Category News Views 5

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 5

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Delta Air Lines' Recent Options Activity Insights

Updated Category News Views 190

Delta Air Lines: Evaluating Current Options Trends Investors are increasingly turning their attention to Delta Air Lines (NYSE:DAL), exhibiting a distinctive bullish trend that signals notable market movements ahead. Today's tracking of public options records reveals compelling activities that should capture the interest of market players. Although the identities of these...

Continue Reading
Brock McKinley's Promotion Marks New Era for Grow Capital

Updated Category News Views 133

Significant Leadership Change at Grow Capital, Inc. (OTCID: GRWC) Grow Capital, Inc. (OTCID: GRWC) has announced the promotion of Brock McKinley to President, initiating a vital transformation in the company's operations and strategy. This decision reflects Grow Capital's commitment to enhancing its position in the fintech landscape by prioritizing innovative...

Continue Reading
Robert Half Declares New Quarterly Dividend for Shareholders

Updated Category News Views 88

Robert Half Declares Quarterly Dividend Robert Half Inc. (NYSE: RHI) recently informed investors about a new quarterly cash dividend. This decision comes as part of the company's ongoing commitment to its shareholders, underscoring its financial health and positive outlook. Details of the Dividend The board of directors has approved a dividend amounting to $0.59 per share...

Continue Reading
Thermal Inkjet Printers Revolutionize Printing Demand by 2035

Updated Category News Views 276

The Rising Demand for Thermal Inkjet Printers The global thermal inkjet printer industry is gearing up for a significant transformation, projected to grow from an estimated USD 2.82 billion to USD 4.22 billion over the years. This remarkable increase represents a compound annual growth rate (CAGR) of 4.1%, driven primarily by heightened demand across diverse sectors such...

Continue Reading
Insightful Overview of Disclosure for Balanced Commercial Property Trust

Updated Category News Views 70

Key Information about the Balanced Commercial Property Trust The Balanced Commercial Property Trust Limited is under scrutiny for public disclosures, particularly from distinguished parties such as Rathbones Group Plc, which holds stakeholder interests exceeding 1%. This article delves into the crucial elements relevant to disclosure regulations, focusing on how such...

Continue Reading